2023

NuGen Medical Signs 5-year Distribution Agreement for InsuJet™ with Verrue Consulting Group in Belgium December 19th, 2023 – Toronto, Ontario

NuGen Medical Signs 5-year Distribution Agreement for InsuJet™ with Advance Medical Life Co. December 14th, 2023 – Toronto, Ontario –

InsuJet™ Registered as a Medical Device in Mexico Second Bulk Sale for InsuJet™ Now Paid in Full November 13th, 2023

Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen’s B2C Business Vertical www.insujet.com – a diabetic e-commerce store November 7th,

MedTech Industry Leader Ian Heynen Commences CEO role at NuGen November 2nd, 2023 – Toronto, Ontario – NuGen Medical Devices

NuGen Medical Appoints Industry Leader Ian Heynen as CEO October 12th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc.

Semaglutide – Ozempic® is Chemically Stable when Administered using Nugen’s needle free InsuJet™ Device October 10th, 2023, Toronto, Ontario –

NuGen Medical Completes Delivery and First Sale of 500 InsuJet™ Devices and Consumables in Romania Toronto, Ontario – September 20th,

NuGen Receives $1.3M Through Early Option and Warrant Exercise September 11th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc.

NuGen Announces Participation at the 2023 Kinvestor Days Virtual Conference Tech Day September 5th, 2023 – Toronto, Ontario – NuGen

NuGen Provides Corporate Update Toronto, Ontario – August 4th, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD)

NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry Toronto, Ontario – July 25, 2023 – Toronto,

NuGen Ships First InsuJet ™ Devices and Consumables to the UK and Attends Diabetes Professional Care Conference Toronto, Ontario –

NuGen Medical Devices receives first bulk-order payment and will ship 500 InsuJets™ to Mexico National Health System (NHS) of the

NuGen Medical Sells 800 InsuJet™ Devices and Consumables in Yemen Toronto, Ontario – June 16th, 2023 – Toronto, Ontario –

Porter Media Engaged by NuGen Medical for Online Marketing of InsuJet™ Beginning with the United Kingdom Toronto, Ontario – June

NuGen Medical Sells 500 InsuJet™ Devices and Consumables in Romania Toronto, Ontario – June 12th, 2023 – Toronto, Ontario –

InsuJet™ Now Registered on NHS Drug Tariff – Covered by Prescription Reliance Medical Group – UK Distributor, 3PL Partner Toronto,

DSRUPT Engaged by NuGen Medical for Online Marketing Toronto, Ontario – June 6th, 2023 – Toronto, Ontario – NuGen Medical

NuGen Medical Announces First Bulk Purchase Order for InsuJet™ Toronto, Ontario – June 2nd, 2023 – Toronto, Ontario – NuGen

NuGen Medical Devices to hold Investor Lunch Presentation in Toronto, Ontario on June 15th, 2023 Toronto, Ontario – May 30,

Nugen Medical Devices Announces Closing of $450,000 Non-brokered Private Placement of Units Toronto, Ontario –May 18, 2023 – Toronto, Ontario

Nugen Medical Devices Announces Closing of $4,000,000 Non-brokered Private Placement of Units Toronto, Ontario –April 25, 2023 – Toronto, Ontario

NuGen Medical Commences Feasibility Study, Validation and Testing for Semaglutide – “Ozempic®” Toronto, Ontario – April 10th, 2023 – Toronto,

NuGen Medical to hold its First Ever Investor Night in Vaughan, Ontario Toronto, Ontario – April 4th, 2023 – Toronto, Ontario

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

Toronto, Ontario – March 31, 2023 – Toronto, Ontario – NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“)

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

NuGen Medical announces the return of Veronique Laberge as Chief Financial Officer and Corporate Secretary Toronto, Ontario – March 10th,

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen“) reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle injections in multiple clinical studies performed in the Netherlands.

NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or “NuGen”) is pleased to announce that the Board of Directors has appointed Mr. Tony Di Benedetto as Executive Chairman and Director.